Jennifer (Ying) Lan

Davis Polk advised the underwriter in connection with the secondary offering of 6,864,545 shares of common stock of Crocs, Inc. by selling stockholders affiliated with The Blackstone Group…

Davis Polk advised the underwriters in connection with the $97.75 million initial public offering of 6,516,667 shares of common stock of Aprea Therapeutics, Inc., which includes 850,000…

Davis Polk advised the representatives of the underwriters in connection with the $163.3 million initial public offering of 9,074,776 shares of common stock of Stoke Therapeutics, Inc.,…

Davis Polk advised the joint book-running managers and representatives of the underwriters in connection with the $64.8 million follow-on offering of common stock of Magenta Therapeutics,…

Davis Polk advised the representatives of the underwriters in connection with the $104.7 million initial public offering of 6,543,500 shares of common stock of TransMedics Group, Inc.,…

Davis Polk advised Marsh & McLennan Companies, Inc. in connection with its SEC-registered offering of $250 million aggregate principal amount of its 4.375% senior notes due 2029. The…

Davis Polk advised Marsh & McLennan Companies, Inc. (MMC) in connection with its SEC-registered offering of €550 million aggregate principal amount of its 1.349% senior notes due 2026…

Davis Polk advised Marsh & McLennan Companies, Inc. in connection with its SEC-registered offering of $5 billion aggregate principal amount of its $700 million aggregate principal…

Davis Polk advised S.A.C.I. Falabella in connection with an offering by S.A.C.I. Falabella and Los Olivos Inversiones S.A., a controlling shareholder of S.A.C.I. Falabella, of 49,669,211…

Davis Polk advised Tyson Foods, Inc. in connection with its SEC-registered offerings of $900 million aggregate principal amount of senior notes in two series, consisting of $400 million…